Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Pharmacogenet Genomics. 2019 Feb;29(2):39–47. doi: 10.1097/FPC.0000000000000363

Table 3a.

Prediction of normal activity haplotype (H2) by *2A (rs16947 and rs1080985) in four populations

Haplotype Frequency in population (%)
EUR ASN AFR AMR
rs5758550 +rs16947 (H2) 22.4 8.2 12 19.9
rs5758550 + rs16947 with rs1080985 (mark by *2A) 21.7 8.2 5.5 19.1
% rs5758550 + rs16947 marked by *2A 96 100 44 95